Profile data is unavailable for this security.
About the company
Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
- Revenue in HKD (TTM)508.40m
- Net income in HKD98.86m
- Incorporated2001
- Employees458.00
- LocationUni-Bio Science Group Ltd13/F, Public Bank Centre,120 Des Voeux Road Central, Central Hong KongHKG
- Phone+852 31023232
- Fax+852 31023737
- Websitehttps://www.uni-bioscience.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Canbridge Pharmaceuticals Inc | 115.38m | -449.91m | 125.33m | 93.00 | -- | -- | -- | 1.09 | -1.06 | -1.06 | 0.2717 | -0.728 | 0.2558 | 2.32 | 3.81 | 1,153,766.00 | -99.74 | -- | -1,160.07 | -- | 63.97 | -- | -389.95 | -- | 0.2146 | -44.04 | -- | -- | 30.26 | -- | 21.64 | -- | -- | -- |
Kontafarma China Holdings Ltd | 836.92m | -63.24m | 173.25m | 717.00 | -- | 0.1628 | 16.90 | 0.207 | -0.0113 | -0.0113 | 0.150 | 0.1904 | 0.4756 | 3.52 | 6.67 | 1,162,388.00 | -4.95 | -1.33 | -6.40 | -2.18 | 59.88 | 54.70 | -10.40 | -4.12 | 1.24 | -6.56 | 0.2116 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
Modern Chinese Medicine Group Co Ltd | 265.36m | 15.84m | 189.00m | 190.00 | 11.93 | 0.3673 | 8.30 | 0.7122 | 0.0264 | 0.0264 | 0.4423 | 0.8577 | 0.482 | 5.62 | 4.24 | 1,389,328.00 | 2.88 | 20.76 | 3.08 | 25.82 | 27.70 | 41.02 | 5.97 | 20.11 | 10.90 | -- | 0.001 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
Wai Yuen Tong Medicine Holdings Limited | 783.88m | -26.68m | 219.40m | 810.00 | -- | 0.1647 | 2.68 | 0.2799 | -0.0228 | -0.0132 | 0.6636 | 1.18 | 0.1721 | 0.4001 | 10.55 | 967,754.30 | -0.1597 | -0.3053 | -0.2538 | -0.5206 | 50.37 | 43.82 | -0.928 | -2.18 | 1.37 | 2.13 | 0.2879 | -- | 8.33 | 0.8488 | -62.16 | -- | 15.35 | -- |
Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.16bn | 35.46m | 244.99m | 1.47k | 6.91 | 0.2348 | 667.07 | 0.2108 | 0.0211 | 0.0211 | 0.6926 | 0.6218 | 0.7383 | 3.11 | 3.99 | 804,883.50 | 1.73 | 3.46 | 2.56 | 5.13 | 37.47 | 49.14 | 2.34 | 4.29 | 2.20 | 29.81 | 0.082 | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
PuraPharm Corp Ltd | 419.41m | -87.09m | 265.25m | 525.00 | -- | 2.03 | -- | 0.6325 | -0.2205 | -0.2205 | 1.06 | 0.3296 | 0.4854 | 1.15 | 5.92 | 633,542.30 | -10.08 | -9.20 | -30.69 | -19.70 | 51.97 | 59.52 | -20.77 | -19.33 | 0.3116 | -1.36 | 0.7597 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
Hin Sang Group (Interntnl) Hldng Co Ltd | 92.62m | -36.71m | 316.62m | 247.00 | -- | 1.52 | -- | 3.42 | -0.0336 | -0.0336 | 0.0848 | 0.1913 | 0.1536 | 2.34 | 10.34 | 374,967.60 | -6.04 | -5.11 | -9.78 | -7.04 | 61.98 | 59.72 | -39.30 | -28.42 | 0.1287 | -1.68 | 0.6054 | -- | 13.70 | -12.83 | 25.84 | -- | -69.21 | -- |
Transcenta Holding Ltd | 24.63m | -395.54m | 452.80m | 200.00 | -- | 0.4229 | -- | 18.39 | -0.974 | -0.974 | 0.0607 | 2.46 | 0.0131 | 0.8106 | 0.5768 | 114,540.40 | -21.08 | -- | -29.77 | -- | 26.02 | -- | -1,606.19 | -- | 1.04 | -31.65 | 0.2826 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
Uni-Bio Science Group Ltd | 508.40m | 98.86m | 474.60m | 458.00 | 4.85 | 1.50 | 3.99 | 0.9335 | 0.0159 | 0.0159 | 0.0812 | 0.0514 | 1.27 | 2.23 | 9.05 | 1,249,140.00 | 24.76 | 1.46 | 32.97 | 1.97 | 83.51 | 80.59 | 19.44 | 1.23 | 2.17 | 168.55 | 0.2267 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
Tianda Pharmaceuticals Ltd | 384.68m | -47.26m | 509.56m | 695.00 | -- | 0.9358 | -- | 1.32 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
3D Medicines Inc | 539.11m | -495.99m | 557.73m | 198.00 | -- | 0.5964 | -- | 1.03 | -2.11 | -2.11 | 2.26 | 3.62 | 0.3746 | 4.94 | 5.79 | 2,722,764.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 694.83m | 1.06k | 11.02 | 0.4055 | 3.54 | 0.5795 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.12 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |